Synthesis and anti-Trypanosoma cruzi activity of β-lapachone analogues

European Journal of Medicinal Chemistry
2011.0

Abstract

The available chemotherapy for Chagas disease, caused by Trypanosoma cruzi, is unsatisfactory; therefore, there is an intense effort to find new drugs for the treatment of this disease. In our laboratory, we have analyzed the effect on bloodstream trypomastigotes of 16 new naphthoquinone analogues of β-lapachone modified in the pyran ring, aiming to find a new prototype with high trypanocidal activity. The new compounds presented a broad spectrum of activity, and five of them presented IC(50)/24 h in the range of 22-63 μM, whereas β-lapachone had a higher value of 391.5 ± 16.5 μM.

Knowledge Graph

Similar Paper

Synthesis and anti-Trypanosoma cruzi activity of β-lapachone analogues
European Journal of Medicinal Chemistry 2011.0
Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones
Bioorganic & Medicinal Chemistry 2008.0
Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi
European Journal of Medicinal Chemistry 2008.0
Trypanosoma cruzi: Activities of lapachol and α- and β-lapachone derivatives against epimastigote and trypomastigote forms
Bioorganic & Medicinal Chemistry 2008.0
On the search for potential anti-Trypanosoma cruzi drugs: Synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions
European Journal of Medicinal Chemistry 2012.0
Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents
Bioorganic & Medicinal Chemistry Letters 2015.0
2-Phenylaminonaphthoquinones and related compounds: Synthesis, trypanocidal and cytotoxic activities
Bioorganic & Medicinal Chemistry 2014.0
Hit-to-lead optimization of novel 2-alkylaminomethylquinoline derivatives as anti-chagas agents
European Journal of Medicinal Chemistry 2020.0
Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides
Bioorganic & Medicinal Chemistry Letters 2010.0